Global Herpes Simplex Virus Treatment Market Size, Status and Forecast 2018-2025

Published On: August 2018 | Report ID: 79466 | Category: Pharmaceuticals and HealthcarePages: 96

This report focuses on the global Herpes Simplex Virus Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Herpes Simplex Virus Treatment development in United States, Europe and China.

The genital herpes treatment includes the use of drug types like Acyclovir that can treat herpes virus infections, including shingles. This medication does not cure herpes, but may prevent herpes sores or blisters. It is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes.

In 2017, the global Herpes Simplex Virus Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study

Novartis

Pfizer

Abbott Laboratories

Sun Pharmaceuticals

Valeant Pharmaceuticals

Teva Pharmaceutical

Dr. Reddy’s Laboratories

Mylan

GlaxoSmithKline

Market segment by Type, the product can be split into

Oral

Injectable

Topical

Market segment by Application, split into

Hospital pharmacies

Online pharmacies

Retail pharmacies

Drug stores

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Herpes Simplex Virus Treatment status, future forecast, growth opportunity, key market and key players.

To present the Herpes Simplex Virus Treatment development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Herpes Simplex Virus Treatment are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Herpes Simplex Virus Treatment Market Size Growth Rate by Type (2013-2025)

1.4.2 Oral

1.4.3 Injectable

1.4.4 Topical

1.5 Market by Application

1.5.1 Global Herpes Simplex Virus Treatment Market Share by Application (2013-2025)

1.5.2 Hospital pharmacies

1.5.3 Online pharmacies

1.5.4 Retail pharmacies

1.5.5 Drug stores

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Herpes Simplex Virus Treatment Market Size

2.2 Herpes Simplex Virus Treatment Growth Trends by Regions

2.2.1 Herpes Simplex Virus Treatment Market Size by Regions (2013-2025)

2.2.2 Herpes Simplex Virus Treatment Market Share by Regions (2013-2018)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Herpes Simplex Virus Treatment Market Size by Manufacturers

3.1.1 Global Herpes Simplex Virus Treatment Revenue by Manufacturers (2013-2018)

3.1.2 Global Herpes Simplex Virus Treatment Revenue Market Share by Manufacturers (2013-2018)

3.1.3 Global Herpes Simplex Virus Treatment Market Concentration Ratio (CR5 and HHI)

3.2 Herpes Simplex Virus Treatment Key Players Head office and Area Served

3.3 Key Players Herpes Simplex Virus Treatment Product/Solution/Service

3.4 Date of Enter into Herpes Simplex Virus Treatment Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Herpes Simplex Virus Treatment Market Size by Type (2013-2018)

4.2 Global Herpes Simplex Virus Treatment Market Size by Application (2013-2018)

5 United States

5.1 United States Herpes Simplex Virus Treatment Market Size (2013-2018)

5.2 Herpes Simplex Virus Treatment Key Players in United States

5.3 United States Herpes Simplex Virus Treatment Market Size by Type

5.4 United States Herpes Simplex Virus Treatment Market Size by Application

6 Europe

6.1 Europe Herpes Simplex Virus Treatment Market Size (2013-2018)

6.2 Herpes Simplex Virus Treatment Key Players in Europe

6.3 Europe Herpes Simplex Virus Treatment Market Size by Type

6.4 Europe Herpes Simplex Virus Treatment Market Size by Application

7 China

7.1 China Herpes Simplex Virus Treatment Market Size (2013-2018)

7.2 Herpes Simplex Virus Treatment Key Players in China

7.3 China Herpes Simplex Virus Treatment Market Size by Type

7.4 China Herpes Simplex Virus Treatment Market Size by Application

8 Japan

8.1 Japan Herpes Simplex Virus Treatment Market Size (2013-2018)

8.2 Herpes Simplex Virus Treatment Key Players in Japan

8.3 Japan Herpes Simplex Virus Treatment Market Size by Type

8.4 Japan Herpes Simplex Virus Treatment Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Herpes Simplex Virus Treatment Market Size (2013-2018)

9.2 Herpes Simplex Virus Treatment Key Players in Southeast Asia

9.3 Southeast Asia Herpes Simplex Virus Treatment Market Size by Type

9.4 Southeast Asia Herpes Simplex Virus Treatment Market Size by Application

10 India

10.1 India Herpes Simplex Virus Treatment Market Size (2013-2018)

10.2 Herpes Simplex Virus Treatment Key Players in India

10.3 India Herpes Simplex Virus Treatment Market Size by Type

10.4 India Herpes Simplex Virus Treatment Market Size by Application

11 Central & South America

11.1 Central & South America Herpes Simplex Virus Treatment Market Size (2013-2018)

11.2 Herpes Simplex Virus Treatment Key Players in Central & South America

11.3 Central & South America Herpes Simplex Virus Treatment Market Size by Type

11.4 Central & South America Herpes Simplex Virus Treatment Market Size by Application

12 International Players Profiles

12.1 Novartis

12.1.1 Novartis Company Details

12.1.2 Company Description and Business Overview

12.1.3 Herpes Simplex Virus Treatment Introduction

12.1.4 Novartis Revenue in Herpes Simplex Virus Treatment Business (2013-2018)

12.1.5 Novartis Recent Development

12.2 Pfizer

12.2.1 Pfizer Company Details

12.2.2 Company Description and Business Overview

12.2.3 Herpes Simplex Virus Treatment Introduction

12.2.4 Pfizer Revenue in Herpes Simplex Virus Treatment Business (2013-2018)

12.2.5 Pfizer Recent Development

12.3 Abbott Laboratories

12.3.1 Abbott Laboratories Company Details

12.3.2 Company Description and Business Overview

12.3.3 Herpes Simplex Virus Treatment Introduction

12.3.4 Abbott Laboratories Revenue in Herpes Simplex Virus Treatment Business (2013-2018)

12.3.5 Abbott Laboratories Recent Development

12.4 Sun Pharmaceuticals

12.4.1 Sun Pharmaceuticals Company Details

12.4.2 Company Description and Business Overview

12.4.3 Herpes Simplex Virus Treatment Introduction

12.4.4 Sun Pharmaceuticals Revenue in Herpes Simplex Virus Treatment Business (2013-2018)

12.4.5 Sun Pharmaceuticals Recent Development

12.5 Valeant Pharmaceuticals

12.5.1 Valeant Pharmaceuticals Company Details

12.5.2 Company Description and Business Overview

12.5.3 Herpes Simplex Virus Treatment Introduction

12.5.4 Valeant Pharmaceuticals Revenue in Herpes Simplex Virus Treatment Business (2013-2018)

12.5.5 Valeant Pharmaceuticals Recent Development

12.6 Teva Pharmaceutical

12.6.1 Teva Pharmaceutical Company Details

12.6.2 Company Description and Business Overview

12.6.3 Herpes Simplex Virus Treatment Introduction

12.6.4 Teva Pharmaceutical Revenue in Herpes Simplex Virus Treatment Business (2013-2018)

12.6.5 Teva Pharmaceutical Recent Development

12.7 Dr. Reddy’s Laboratories

12.7.1 Dr. Reddy’s Laboratories Company Details

12.7.2 Company Description and Business Overview

12.7.3 Herpes Simplex Virus Treatment Introduction

12.7.4 Dr. Reddy’s Laboratories Revenue in Herpes Simplex Virus Treatment Business (2013-2018)

12.7.5 Dr. Reddy’s Laboratories Recent Development

12.8 Mylan

12.8.1 Mylan Company Details

12.8.2 Company Description and Business Overview

12.8.3 Herpes Simplex Virus Treatment Introduction

12.8.4 Mylan Revenue in Herpes Simplex Virus Treatment Business (2013-2018)

12.8.5 Mylan Recent Development

12.9 GlaxoSmithKline

12.9.1 GlaxoSmithKline Company Details

12.9.2 Company Description and Business Overview

12.9.3 Herpes Simplex Virus Treatment Introduction

12.9.4 GlaxoSmithKline Revenue in Herpes Simplex Virus Treatment Business (2013-2018)

12.9.5 GlaxoSmithKline Recent Development

13 Market Forecast 2018-2025

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2018-2025)

13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@marketresearchplace.com

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.